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Simultaneous bone marrow and intestine transplantation promotes 
man-ow-derived hematopoietic stem cell engraftment and chimerism 
Atsunori Nakao, Hideyoshi Toyokawa, Kei Kimizuka, Michael A. Nalesnik, Isao Nozaki, Robert J. Bailey, Anthony J. Demetris, 
Thomas E. Starzl, and Noriko Murase 
Organ allografts have been shown to pro-
vide a syngeneic microenvironment for 
organ-based donor hematopoietic stem 
cells to maintain long-lasting chimerism 
after transplantation. We hypothesized 
that organ allografts would also support 
engraftment and hematopoiesis of adjunc-
tively infused donor marrow stem cells, 
syngeneic to organ grafts, in nonmyelo-
ablated recipients. In BN-to-LEW and GFP-
to-ACI rat combinations, donor bone mar-
row (BM) infusion together with small 
intestine transplantation (SITx) under 
short-course tacrolimus immunosuppres-
sion resulted in persistent macrochimer-
ism (more than 5%) for 150 days. In con-
trast, after BM infusion or SITx alone, 
chimerism was temporary and disap-
peared by day 100. V-chromosome poly-
merase chain reaction (PCR) in sex-
mismatched male BM plus female 
intestine or female BM plus male intestine 
transplantation into female recipients sug-
gested that persistent macrochimerism 
was derived from infused BM. BM infu-
sion together with lymphoid-depleted in-
testine grafts also supported macrochi-
merism development; however, third-
party intestine grafts did not. After GFP-
positive BM plus wild-type (WT) SITx into 
ACl,large numbers of GFP-positive leuko-
cytes were found in WT intestine grafts. 
Isolated cells from WT intestine grafts 
developed GFP-positive CFU-Cs and 
propagated multilineage GFP-positive leu-
kocytes when adoptively transferred into 
lethally irradiated WT recipients. These 
findings suggest that intestine allograft 
supports simultaneously infused donor 
(syngeneic to organ grafts) marrow stem 
cell engraftment, differentiation, and per-
sistence of chimerism. (Blood. 2006;108: 
1413-1420) 
<D 2006 by The American Society of Hematology 
Introduction 
Long-lasting micnKhimcrism was found in organ allograft recipi-
ellis treated with conventional iml1lunosuppression in clinical and 
experimental studiesL ' The longevity (decades in humans) and 
Illultilinc'lgc features of persisting donor leukocytes in organ 
allograft recipients suggest the presence of hematopoietic stem 
cells in organ allografts and their proliferation/differentiation after 
1I·<lnsplantatilln.'·4 This finding is consistent with reccnt nUI1lCI'OU, 
reports demonstrating that stcm cells arc present in multiple adult 
tissues; however. the identification. behavior, and characterization 
of the specific stelll cells in adult tissues oUhide of the hone marrow 
(13M) haH' not been established5.h 
Apart from microchimerism associated with organ transplanta-
tion, the establishment of hematopoietic (macro)chimerism has 
heen long known to associate with stable donor-specific immuno-
logic tokrance.7•X and the creation of hematopoietic chimera using 
donor marrow stem cells has been an attractive approach in the 
lield of ol'gan transplantation to obtain drug-free allograft accep-
t.lnce 9 . f I Because this procedure requires the repopulation of the 
hematopoietic stelll cell compartment with infused donor marrow 
cells after host myeloablative conditioning. the engraftmcnt of 
donor stelll cells into host marrow microcnvironment is the crucial 
ekillent in success of the strategy. In this regard. the marrow 
microenvironment. recognized as "niches." has important roles by 
p['()vitiing a proxim.ne relationship of stelll cells with stroma cells 
dnd extracellular matrix. f2.f3 Previous experiments demonstrated 
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that transplantation of the microenvironment together with marrow 
stem cells permitted stable marrow stem cell engraftmellt without a 
recipient conditioning regimen; bone fragments under the kidney 
capsule. vascularized bone grafts as a palt of composite hind limb, 
or vascularized sternulll grafts resulted in stable hematopoietic 
chimerisl1l. 14- fh The comparable finding in organ transplantation is 
that the organ allograft parenchyma provides a syngcneic micl'Oen-
vironment for organ-based hematopoietic stem cells for the maintc-
nance of multilineage chimerism after solid organ transplantation. f 7 
Considering the significance of the relationship between stem 
cells and the microenvironment, we hypothesized that organ 
allografts would provide a syngcneic microenvironment not on Iy 
for the organ-based donor stem cells but also to adjunctively 
infused donor marrow cells. Accordingly. using a small intestine 
transplantation (SITx) model, this study examined the roles of 
allograft parenchyma in supporting the engraftment of simulta-
neously infused allogeneic marrow hematopoietic ,tem cells. The 
resliits demonstrated that thc cngraftillent was negligible when 
allogeneic marrow cells were infused alone into noncytoablatcd 
rccipients under the coverage of tacrolimus immunosuppression; 
however. donor marrow stem cell engraftment and persistent 
multilineage rnacrochimcrisll1 were achieved when donor BM was 
infused together with intestine allografts. SimultaneoLisly infused 
donor marrow stem cells prcferably engrafted into intestine grafts. 
The study suggests that the presence of intestine allografts supports 
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lh~ cngrartmcnt of allogcneic marrow hcmatopoietic stem cells into 
major histocompatibility complex (MHC)-matehed microenviron-
ment (If intcstinc ."rai'ts. 
Materials and methods 
Animals 
(;reen flu,)re,cent protein (GFPHran,gcnic and Wild-type (WT) Sprague 
Dawley (SD) rats <lriginally generated by Dr Masaru Okabe (University of 
(haka. Japan I":" were obtained from Japan SLC [Hamamatsu. Japan). The 
cxprlDII~itF1l ofGFP yya~ under the c\)l1tr01 nf the cytomegalovirus eniJancer 
and the chicken ~F-alDti[F promoter derived from all expression \'l'ctor, 
pc/V,CiS,I'-:" Inbred W"; (RTI"). LEW (RTI'). and ACI (RTI"J rats 
weighing I SO to 25() g were purchased from Harlan Sprague Dawley 
(indianapolis. IN), All animals wcre maintaincd in a laminar flow animal 
facility :It the Uni,er,ity of Pittsburgh and fed with a ,tandard diet ad 
libillnn, ,-\11 procedures in Ihis experiment were perfonll,,,1 according to the 
guideline" of the Coulll'il on Animal Care at the rniyDi~rsity of Pittsburgh 
"11(1 the National Researeh Council's Guide for the Humane Care and Use of 
Laboratory Animals. 
Transplantation procedures 
Ortholopic SIT, with caval drainage was perfonned as previously de-
scribed.:' The donor small intestine from the ligament of Treit7 to the 
iil'occc'al valv'e was isolated on a vascular pedicle consisting of the portal 
vein ,lrHl of the superior mesenteric artery in continuity \vith a segment ot 
aona, TIll' graft was pl'rfllsed via the aortic segmenl wilh 5 mL chilled 
lactated Ringer solutioll. and the intestinal lumen was irrigated with 20 mL 
cold \aline ,",olution clllltaining O.5(1t neomycin sulfate (Sigma, St Louis, 
MO) Thc entire recipient intestine, including gut-associated lymphoid 
tiS:-.lll' (('ALT). wa.., removed and cnd-to-side anastO!llOSeS between the 
graft anrta and the recipient infrarenal aorta and hL't\\-cCIl the graft portal 
,'ein and host 'ena cava were performed. Enteric contilluity was restored 
by proximal and distal end-to-end intestinal anastomoses. All recipient 
animals were gi,en 20 mg/d prophylactic cefamandole nafate for 3 
PO<;!(l]K'r;nivc Liays 
Bone marrow isolation and infusion 
lin fractionated 13M cells were obtained by flushing the tibias and femurs. 
Cel" wcre proees,sed with RPMI 1640: supplemented with 25 mM HEPES. 
2 lll".ll-"lutamine. 5() I-Lg/mL gent'linicin. and 10% fetal hovine serum (all 
from Life Technologies. Grand Island. rs;y I: and then pa"et! through nylon 
lllesh to sl:parate the remaining connective tissue fragments. 2:' Trypan blue 
",ciusion testing uniformly ,howed more than 95'1< cell viability. A total of 
25 x lOx viable cells were intravenously injectcd into the recipient via the 
juglilar PI" penile veill.:;:;·:;' 
Reagents and procedures 
Tacrolimus (TACI (Astellas Phanna. Tokyo. Japan) was administered 
intralllusl'lilarly with a daily dosage of 1.0 mg/kg on day () to day 13 with 
additional single doses on day 2() and day 27.2: Rabbit anti-rat lymphocyte 
.serum (ALS) [Accurate Chemical & Scientific, Westhury. NY) was 
intr<lperil(1I1eally injected fllr 3 days with a daily dose of I,ll mL. This do.sl' 
of AI,S ettectivcly decrca,ed circulaling T cells to less than 5%.24 Ex vivo 
irradiation of the harvested intestine graft (9.5 GYJ in cold lactate Ringer 
\oiUlion in a )() !TIL Fakon tube was performed lIsing a D7Cs source 
(e,ammacell f()()() Elite: NOflJion International, Kanata. ON. Canada)." 
Flow cytometry 
Affinity-purified biotinylated rat monoclonal antibodies (mAhs) 163 (rat 
IgG2b) and 42 (rat IgG2a) were used to detect RTIAI (MHC class I) on 
LEW and RTIA" :lnligcns on BK respectively." Phycnerythin (PU 
cnniligall'd streptavidin (PharMingen. San Diego. CAl was used as a 
seCllllllar) antihody_ Line<lges of leu"ocyte, were analyzed with fluore,celll-
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cnnjugated mAhs R7.3 (a(3TCR; PharMingen), anti-rat IgM [Organon 
Teknika, Durham, NC), OX33 (CD45RA, B cells; PharMingen). NK-'.2.3 
(NKR-PI. natural killer rNK] cells: PharMingen), EDI (macrophage.s 
CD68: Scrotec. Kidlington. Oxford. United Kingdom), ED2 (macrophage 
CD163: Serotec). and OX42 (CDllb; Serotec). The sample, were fixed in 
parafnrmaldehydc ancl analyzed on a Coulter Elite ESP (Coulter. Miami. 
EL). [sotype-matched nonspecific antibodies were used for the control. 
Routine histopathology and immunohistopathology 
Forrnalin-tixed tissues were embedded in paraffin. sectioned ut 4 fUlL and 
stained with hematoxylin and eosin, The slides were blindly reviewed hy 
one of the authors (M,A.N,) without knowledge of experimental group', 
The degree of epithelial injury of intestine allografts was determined by the 
frequcncy of apoptosi.s in crypt epithelial cells. The numbers of lymphoid 
nodules and Peyer patches (PI's) in the intestine were counted and 
expressed as the number per section, The presence of mesenteric fihrosis in 
mesenteric lymph nodes (MLNs) and severity of mesenteric aneriopathv 
were graded as 0 (none), I (mild), and 2 (.sevel·e). 
Cryosel'tiOIlS were .... tained with immunofluorescent technique u\ing 
OX27 (I :200: Serotec) that recognized BN, but not LEW, MHC ciass I 
antigens. Double staining was with OX27 followed by PE-conjugated 
anti-mouse IgG and FTTC-conjugated anti-rat IgM. To detect GFP-positive 
cells in ti-;sues, samples \vere obtained hy perfusing animals via the 
abdominal aorta with phosphate-huffered saline (PBS) follmveu with 2',1 
paraformaldehyde in PBS. Tissue samples were stored in 2% paraformalde-
hyde for several hours at 4°C, eryoproteeted in 2.3 M sucrose in PBS 
overnight. emhedded in OCT compound, and frozcn in liquid nitrogen-
cooled i,opentane. Salllpies were cut into 6-l-Lm sections. nuclear DNA 
stained with Hoechst dye (bi . sbenzimideJ. and visualized with an Olympus 
BXSI epifiuorescence microscope (Malvern, NY) equipped with an 
Olympus MagnaFirerM CCD camera (Goleta. CAl and interfaced with 
MagnaFire image software. GFP-positive cells were counted per 500 nuclei 
in 8 to 10 high-power fields (HPF) in each section. and the result w~" 
expre"cd as the percenlage orGFP-positi,e cells. 
Real-time PCR 
Real-time polymerase chain reaction (PCRI ror sex-determining region of 
Y chromosome (SRY I gene was used to determine the concentration or 
male cells in the sample. Genomic DNA of peripheral blood lllononucicar 
cells (PBMCs) and recipient tissues were prepared using QIAamp kit 
(Qiagen. Chatsworth. CAl as described by the manufacturer. PCR reaction 
mixture was prepared u,ing SYBR grcen PCR master mix (Perkin Ehner-
Foster City. CAl using the primers of AAGTCAAGCGCCCCATGA 
(sense) and TGAGCCAACTTGTGCCTCTCT (antiscn,e).:"c7 The reac-
tions were performed using an ABI7000 Prism Sequence Detection System 
(Perkin Elmer). The thermal cycler was configured as the following: 
incubation 195°C. 10 minutes). 40 cycles of denaturation (95"C. 15 
seconds). and annealing and extension IhO"C. 60 second,s)_ The stand~grE1 
curves for the presence of SRY were prepared by mixing male and female 
DNA in various proportions (IOO'Yr., 20%. 4c/t-. OWlr" 0.16%), Each run 
consisted of standard and a negative control without template. 
CFU-C assay 
Leukocytes from MLN.s were isolated hy injecting RPMI 1114() into MLNs 
and by ti Itration through nylon mesh. Lymphocytes in pp, werc obtained <IS 
previously descrihed2s I3rietly. after the muco.sal layer of till' intestine wa.s 
disrupted. PPs were excised: cut into smali pieces; digested in" water bath 
for 30 minutes at 37"C with RPMT 1640 containing 0.050/< collagenase 
(type B: Boehringer Mannheim, Mannheim. Germany). 2(ft FBS. 10 my I 
HEPES. and 50 fLg/mL gentamicin (Life Technologies): and passed through 
nylon me'Jh to separate the remaining cOllnective tis~lfe fragments from 
leukocyte fraction. Isolated cells were washed twice with RPMI 1640 
containing 5% FBS and further purified by centrifugation over Ficoll-Paque 
(specific gravity. 1.077: ilmersham Biosciences, Uppsala. Sweden). The 
interface was collected and washed twice with RPMI 1640 containing 
5% FIlS. 
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""lated leukocytes fmm MLNs and PI's were resuspended in "cove 
modified Dulhecc[) medium with 2% PBS (2'/( IMOM) (StemCeJl Technolo-
~ie" YanC<luver, Be. Canada). The cells (1.S X 1(J4) in (), I mL of 2% 
IMD'l were mixed "ith 1.0 mL mclhylcellulose-hased media in the 
prl'seneC' of stelll cell factor. G'vl-CSF. and IL-3 (MelhoCult, StemCeli 
Technologies). A lotal ""pension \olurne of I, I mL was plateu in a :lS-rnm 
dish. These dishes were placed in ISO-mm dishes with", to .:I mL sterile 
\\llter for humidity and incuhated at ,neC with )',; CO, and at leasl 95% 
humidity. At 10 days of culturing, colonies (more than 30 cells per 
aggresat~F were countcJ as CFLLC cOllnts by inverted microscope and an 
Olympus SZX 12 fluorescence dis>ecting microscope for conlirmation of 
df;m~pyFsilive C()]onies. 
Statistical analysis 
All tillill ill this study were expressed liS mean'S/), Results of flow 
cytlllllell'Y and histopllthology were analyzed by I-way analysis of variance 
(ANOYA) and the Fisher projected least significance difference (PLSO) 
test. A P value of less than .OS was considered to be significant. 
Results 
Development of macrochimerism with simultaneous 8M 
and intestine transplantation 
LE\V n:cipienls received the intestinc. BM. or intestine plus BM 
frolll fully allogeneic BN donors under short-course TAC immuno-
suppression. and the perccntages of donor cells in the pcripheral 
blood were sequentially studied by flow cytometry. [n recipients of 
S ITx alone, donor cells during the first week after SITx were a 
tllean of LJ.l)(k. However, they gradually decreased and disappe~trcd 
by day 120. After BM infusion alone. donor cells slowly increased 
and reachcd 5.Wl ::':: 1.3% during the second month. Thereafter, 
chimerism lIas not maintained. and donor cells disappeared by day 
90. In contrast. when 8M was infused together with SITx, higher 
A B 
• 
• 
• • 
• • 
• 
• • 
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levels of donor cells (10% to 15%) were cktected early after SITx. 
and stable blood chimerism more than 5% was maintained for more 
than 150 days (Figure I A). 
Numbers of donor cells in recipient splecn at day 150 correlated 
well with peripheral blood chimerislll levels. No donor cells wen: 
found in the recipient spleen after BM or SIT, alone, while 
multilineage donor cells (2% to 8%) were found in the spleens of 
simultaneous BM plus SITx recipients, The Illultilineage feature of 
macrochimerism at day 150 suggests the engraftment of donor 
stelll cells in recipients of BM plus SITx. Interestingly, B cells were 
a predominant popUlation among donor cells (Figure I B-C), 
Immunohistochemistry of the spleen confirmed abundant OX27-
positive donor B cells in the splenic B-cell follicles of simultaneous 
8\11 plus SITx rccipiellls (Figure I D), 
Intestine allografts are chronic rejection-free and maintain 
donor leukocytes when 8M and intestine 
are simultaneously transplanted 
Histopathologic analysis of allografts at day 150 revealed the 
development of chronic rejection (CR), including the depletion of 
lymphoid components and fibrotic changes of GALT, and the 
presence of arteritis, when the intestine was transplanted alone 
(Table I), In accordance with our previous srudics,'u4 thesc 
changes wcre completely prevented in intestine allografts with 
simultaneous BM infusion, The Ilumbers of PPs and lymphoid 
nodules in intestine grafts of SlTx plus 13M recipients were similar 
to those seen in norlllal intestine, and there was no fibrosis or 
arteritis in graft MLNs with simultancous BM infusion. 
To investigate levels of chimerism in intestine allografts, 
single-cell suspension was prepared from graft MLNs. Because of 
the "evere fibrosis of graft MLNs in the SITx-alonc group. the 
number" of lymphocytes recovered from graft MLNs were not 
sufficient for flow cytomctric analysis. In contrast. graft MLNs in 
D 
;,k:v' 
• I 
'. , t~ 1 
f ., ~ • ~ :~ I-r .. :,·1 T): 
Figure 1, Development of multilineage chimerism after simultaneous BM plus SITx. but not after BM infusion or SITx alone, in BN-to-LEW combination under 
short·course TAC immunosuppression, (A) Flow cytometric analYSis of blood chimerism with mAbs for donor MHC class I. Transplantation of intestine alone (n ~ 10) 
showed an early high-level chimerism at day 14, Donor cells gradually decreased and disappeared at day 120. After BM cell injection alone (n = 6), donor cells gradually 
increased with a peak (2% to 6%) at day 40, slowly decreased, and became undetectable by day 90. On the contrary, when BM and intestine were transplanted together 
(n -, 12), augmented macrochimerism (3% to 10%) was maintained for 150 days, • P -c' ,05 versus BM or SITx alone, (B) B-cell-dominant multilineage chimerism was seen in 
both host spleen and intestinal graft MLNs 150 days after BM infusion plus SITx. Donor cells were not identified in recipients of BM or SITx alone: n ~ 3 to 7 for each group, 
• P ,05 versus BM or StTx alone. N/D indicates not detected; N/A. not applicable, (e) Representative flow cytometry of the blood taken at day 150 from 1 of the recipients of 
BM plus intestine transplantation. Result demonstrates multilineage macrochimerism, including donor T, B, and NK cells and macrophages, (D) Double fluorescent 
immunohistochemical staining of host spleen with OX27 (BN MHC class I. red) and anti-rat IgM (8 cell, green), Abundant OX27-positive donor cells were found in the B-cell 
area of the spleen at day t 50 after BM infusion plus SITx but not after SITx alone (40x/O,75 numeric aperture [NAI oil-immersion objection), Images are representative of 3 
animals per group 
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Allograft histopathology 
Intestine MLNs 
Blood No. of lymphoid 
No. of chimerism, No, of apoptosis No, of PPs nodules per Fibrosis 
grade 
Arteritis 
grade Transplant recipients day 150, % per 10 crypts per section section 
Normal intestine 4 NA 0,5:': 0,6 
Intestine alone 10 0 2,0:': 1.1 
Intestine and BM 12 4,2:': 3,8' 1.2 :': 0,5 
Irradiated Intestine alone 5 
° 
1.8 :': 0,8 
Intestine from ALS-pretreated donor alone 7 
° 
2,0 :': 1,2 
Irradiated intestine and BM 8 1.9 :': 1,0' 1,3:': 0,8 
0,30 :': 0.50 1,65:': 0.42 
0,03:': 0,06 0,56:': 0,50 
0.28 " 0,21' 1.24:': 0.47 
0,02 - 0,02 0.48" 032 
0,02:': 0,05 0,84 0.46 
0,19:': 0,16' 1,00:': 036 
° 1,00 ": 1.07 
0' 
1,80 ::' 0,83 
0,86::': 0,70 
0' 
° 0,20 • 0.42 
0' 
0,20::': 0.45 
0,14::': 0,24 
0' 
Intestine from ALS-pretreated donor and BM 11 5,0:: 3,0' 2,1 • 0,5 0,20:': 0,14' 1.12 :': 0,58 0' 0' 
BN-to-LEW SITx under TAe 1,0 mg/kg on days 0-13,20. and 27 after SITx, Data represent mean::': SO, 
NA indicates not applicable, 
'P ,OS versus Intestine alone (1-way ANOVA and Fisher PLSD), 
the SITx plus 13M group were wcll populated. and tlow cytomctry 
showed a total or 9,3% ± O,7Mi, donor cells. including donor T. 13. 
and NK cclh (Figure IB), 
Origin of macrochimerism after simultaneous intestine 
and 8M transplantation 
After we obserVL"d that infusion of allogeneic BM with SITx in 
nOllcyloablated recipients resulted in persistent macrochimerism. 
we next dL"lermined whether chimeric donor cells in these recipi-
elll, were derived frolll the intestine or 8M graft using sex-
mismatched transplantation, In these experiments, female LEW 
recipients rccei\ed either ll1ule BN intestinc plus female BN BM or 
female BN intestine plus male BN BM. Using flow eytoll1ctry. 
fcmak LEW recipients or sex-mismatched BN intestine and 13M 
grafts \\'('tl: cOlilirmed to have the similar levels of macro chimerism 
at day ISO as seell in maic recipients. Levels of chimerism derived 
from mak grath wcre detCl'mined using quantitative real-timc PCR 
for SRY When male intestine and female B[\1 were transplanted, 
male D"IA wa, detected carly after transplantation and disappeared 
by 90 days, while flow cytol1lctry detected 3,9% ± 2,ork donor 
cells al day ISO (Figure 2A), On the contrary. after transplantation 
of male 8\1 and female intestine, the nwic DNA concentration 
gradll~tlly increased and became nearly equal to the level of 
chimerism detccted with How cytoll1etry by day 150, These results 
indicate Ihat most chimeric donor cells found early after simulta-
neous intestine ane! BVI transplantation were from intestine allo-
grafts, In contra,t. BM-derived donor cells gradually increased 
with lillle. and donor chimeric cells in the hlood at day 150 were 
largely from the infused BM (figure 2A-B). 
BM-derived cells distribute into intestine grafts as well as 
recipient lymphoid tissues 
Dislribution of BM-derived 8N donor cells in various LEW 
recipient ti"ues at day ISO lifter simultaneous female intestine plus 
lI\ale 13M transplantation was analyzed hy PCR for SRY. BM-
derived male signals were mainly found in graft (female) GALT. 
including pp, ~lf1d MLNs. Host spleen also had male signals. On 
the other hand, very few male signals were detected in host 
non lymphoid organs, such as the liver. heart, and tongue, BM 
contained mostly progenitors with small numhers of mature cells, 
and reci.pient 13M showed less than I fir donor BM-dcrived male 
signals at day ISO (Figure 2C). 
Depletion of intestine graft passenger leukocyte does not 
prevent macrochimerism development 
To investigatc whether GALT leukocytes in intestine grafts play 
roles in developing macrochimcrisill after SITx plus marrow 
A 
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Figure 2, Origin of donor cells in peripheral blood after BN-to-LEW BM plus 
intestine transplantation. (A) Peripheral blood chimerism in female recipients of 
male BM plus female intestine or female BM plus male intestine grafts was analyzed 
by flow cytometry (BN MHC class I) and quantitative real-time V-chromosome peR. 
Results demonstrated that most donor cells in the blood at 7 days after transplanta-
tion consisted of passenger leukocytes from intestine allografts, However. intestine 
graft-derived cells disappear by day 90, In contrast, BM-derived donor cells gradually 
increased. and almost all donor cells were of infused BM origin at day90 and day 150; 
n ~ 3 to 4 for each group, (B) PCA analysis of PBMCs with primers for SRY at day 
150, When female BN intestine and male BN BM were transplanted into female LEW 
recipients, male DNA band was identified, On the other hand. transplantation of male 
intestine and female BM resulted in undetectable SRY band in the blood at day 150. 
while lIow cytometry detected 3,9% donor cells, suggesting that macrochimerrc donor 
cells at day 150 were mainly derived from infused donor BM cells. Blot is 
representative of 2 independent experiments from 3 to 4 rats per group, (e) Real-time 
peR analysis for SRY in various female LEW host organs at day 150 after female BN 
intestine and male BN BM transplantation, Male DNA derived from BN BM was mainly 
found in graft GALT (PP and MLN). cervicatlymph node (CLN). and host spleen (Sp), 
Very few infused BM-derived cells were found in host heart (Ht), liver (Lrv). tongue 
(Ton), or bone marrow (BM); n ~ 3 for each group. 
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Figure 3. Sequential blood chimerism after BM infu· A 
sion with leukocyte-depleted intestine grafts. (A) 
Donor BN cells in LEW recipients of leukocyte·depleted 
intestine grafts without donor 8M infusion became unde-
tectable by day 120. (8) In contrast. donor BM infusion 
together With transplantation of leukocyte-depleted intes-
tine grafts resulted in persistent macrochimerism. ALS K~; 
indicates donor ALS pretreatment for 3 days (1.0 mL; day 
-3 to -1); Rad. ex vivo 9.5 Gy graft irradiation .• P c, .05 ~ 
versus naive SITx (without lymphoid depletion); AP < .05 
versus corresponding group without donor 8M at the 
same time point. 
infu.sion. wc next cxamincd sequcntial changes of blood chimcrisl1l 
aftcr BM infusion and SITx when intestine leukocytes were 
climinatcd by donor ALS prctreatment or cx vivo graft irradia-
tion. 2.B ! Early chimerism was significantly reduced after transplan-
tation of lcukocytc-climinated intestine grafts alonc 
(0.1 'i'k :+: 0.01 % with ex vivo graft irradiation and 2.75% :+: O.RY;;' 
with ALS donor pretreatmcnt) compared with those of nondepleted 
intestine grafts (9.94% :+: 0.99%). In all rccipients without BM 
infusion, donor cclls quickly disappeared (Figure 3A). When BM 
w"s infuscd together with leukocyte-depleted intestine grafts. early 
chilllcrism InTis wcrt: low; however, donor eelb gradually in-
crcased. and macrochimerism was maintained with 1.4% to 11.5%· 
at day 150 (Figure 3B). Histopathologically, leukocyte-depleted 
intestinc grafts also were chronic rejection-frcc when BM was 
simultaneously infused ITable I). 
GFP 8M cells induce macrochimerism when a syngeneic 
intestine graft is simultaneously transplanted 
To fUrlht:r confirm tile engraftment of BM-dcrived stem cells 
and to dctermine the site of engraftment, we next employed BM 
plus SITx experiments using GFP transgenic rats. GFP BM was 
infused into fully allogeneic ACI rats with or without WT 
intcstinc grafts under hriefTAC immunosupprcssion. Sequential 
110\1 cytol1lctric analysis of GFT'-positivc cells in host hlood 
sam pies confirmed the finding in the BN-to-LEW combination 
model that GFP-positive-infused BM-derived cells gradually 
incrca,cd in recipicnt> and maintained levels above 5C;() for more 
than 120 days whcn 8M was infused simultaneously with SITx. 
After CFT' BM infu,ion or GFT' SITx alone. GFP-positive cells 
wcre only temporarily secn in the blood and stable macrochimer-
ism was not established (Figure 4). 
Further, stahle long-term macrochimerism was achieved only 
when H\J cclls and simultaneously Iransplantcd intestine gl'afts 
were syngcncic. because GFP BM infusion together with third-
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party intestine (BN) did not maintain stable macrochimerism. The 
result suggested thai syngeneic intestine graft supported the 
engraftment of simultaneously infused marrow stem cells and the 
development of macrochimerism (Figure 4). 
Infused BM-derived GFP-positive cells repopulate intestine 
grafts and host secondary lymphoid organs 
In animals with stable blood macrochimerism at day 120 after GFP 
BM plus WT SITx. GFP-positive cells were detected by tlow 
cytometry at similar levels (about YYr) in graft GALT (eg, MLNs. 
PPs) of WT intestine graft as well as host spleen and lymph nodes 
(Figure SA). However, GFP-positive cells were remarkably less in 
host bone marrow and thYlllus. Location of GFP-positive cells was 
studied with fluoresccnt microscopic analysis. and results revealed 
a homogeneous distribution of GFP-positive cells in the graft 
lymphoid organs. Few GFP-positive BM-derived cells were seen in 
the recipient liver. heart, or BM, probably due to less frequency of 
mature leukocytes in these tissues (Figure 5B-C). 
Infused marrow-derived stem cells engraft into simultaneously 
transplanted intestine grafts, which are syngeneic to stem cells 
Based on the findings that infused BM-derivcd multilineagc 
macrochimerism was maintained for more than 150 days when the 
intestine graft (syngeneic to marrow cells) was simultaneously 
transplanted, we hypothesized that marrow-derived donor hemato-
poietic stem cells engraftcd into the syngeneic microenvironment 
provided by intestine grafts for differentiation, To investigate this 
possibility, we conducted in vitro and in vivo assays to delcct 
infused marrow-derived hematopoietic stem cells in intestine 
grafts, At day 120 after GFP BM and WT intestine grafts were 
transplallled into ACI rat recipients under brief TAC immunosup-
pression. leukocytes were obtained from GALT of WT graft 
intestine as well as host BM. When BM cells taken from ACI 
BM (GFP) SITx (GFP) SITx (GF;) BM (GFP) SITx (WT) BM (GFP) SITx (BN) BM (GFP) 
[ 
I': 
1" 
12:) 41· GO 1;::' 
days after transplantation 
Figure 4. Sequential blood chimerism of ACI reCipients after transplantation of GFP, WT, or BN (third-party) intestine plus GFP'positive BM under TAC 
immunosuppression. Similar to results of BN-to-LEW SITx experiments, donor-derived GFP-positive cells gradually decreased with time in reCipients that received 
GFP-posltlve 8M or GFP-positive SITx alone. Transplantation of GFP-positive intestine and GFP-positive BM resulted In stable macrochimerism for 120 days. Stable long-term 
macrochimerism was also achieved when WT intestine graft and GFP-positive BM were transplanted together. However, cotransplantatlon of third-party Intestine (BN) and 
GFP-posltlve 8M did not result in a long-lasting macrochimerrsm .• P < .05 versus BM or SITx alone: n ~ 4 to 13. 
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Figure 5. Distribution of 8M-derived GFP-positive cells after GFP-positive 8M 
plus WT intestine transplantation. (A) Flow cytometric analysis of lymphoid organs 
in recipients 01 WT intestine plus GFP-posltlve 8M at day 120. From 4% to 6% 01 
GFP-positive cells were seen in the mesenteric lymph nodes (MLN) and Peyer 
patches (PP) of WT intestine grafts. Host spleen (sp), cervical lymph nodes (CLN), 
and blood also showed similar levels of macrochimerism. On the other hand, there 
were lew GFP-positive cells in recipient BM and thymus (Thy); n = 4 to 5. (B) 
Fluorescent microscopic analysis of various organs in the recipients of WT intestine 
plus GFP'positive BM at day 120. Numerous GFP-positive cells were seen in graft 
MLNs and PPs as well as host spleen. Only few GFP'positive BM-derived cells were 
Identified in recipient liver (Liv). heart (Ht), or BM. Blue indicates nuclear stain; 
40:- /0.75 NA oil-immersion objective was used. (C) Percentages of GFP·positive 
cells. GFP-positive positive cells were counted In the section and expressed as the 
percentage to the number of nucleus. 
recipients were cultured in a methylcellulose-based culture system 
for CFU-C assay. about 150 colonies per 1.5 X l()5 cells were 
developed. However. Ihere were very few GPP-positive colonies 
( I. I 2: 0 . .12 pCI' 1.5 X 10' cells). and most of the colonies were 
(JFP negative. 111 contrast. when isolated cells from PPs and MLNs 
of WT grafts were cultured for CFU-C assay. most of the developed 
colonies were GFP positive (more than 90%) with frequencies of 
6.5 = 4.1 and 0.9 :+: 0.1 per 1.5 x I ()5 cells, respectively. Although 
total cru-c counts of GALT leukocytes were low compared with 
those of 8M cells. GALT of transplanted intestine tended to have 
more CFU-Cs than naive WT intestine (Figure 6). Nevertheless, the 
frequency of GFP-positive colonies remained at a similar low level 
in hOlh host bone marrow and graft GALT. In vitro propagated 
colonics were mostly composed of ED2-positivc macrophages. 
and negative stain with mAb R7.3 (a [3TCR) excluded the 
possibility thai the colonies were due to mixed lymphocyte 
rca<.:lions (data not shown). 
To further confirm the engraftment of marrow-derived GFP-
posilive stem cells into intestine grafts, GALT leukocytes wCI'e 
obt<tined from WT gr<tn after GFP 8M plus WT intestine transplan-
tation. Isolated cell>, were adoptively transferred into lethally (9.5 
Gy whole body irradiation. InCS Gammacell 40) irradiated WT 
animals together with naive WT 8M cells (2 X IOC> per animal). 
Plow cytomctric analysis of peripheral blood was performed at day 
100 to evaluate whether GFP-positivc stem cells in WT intestine 
grafts propagated in these animals. When host BM cells (120 days 
after GFP-positive BM plus WT SITx) were transferred into 
irradiated WT recipients. 1.1 'Ie ::!: O.8 LIt) GFP-positive cells were 
found in Ihe peripheral blood. Transfer of cells from WT intestine 
graft t\lLNs and PI's resulted in S.9'lt :+: OAck (JPP-positive cells, 
BLOOD, 15 AUGUST 2006' VOLUME 108, NUMBER 4 
while cells from naive GFP rat MLNs and PPs res lilted in 
0.8% ::!: 0.9% GPP-positive cells (Table 2). Propagated GFP-
positive cells included T cells. B cells. and monocytes/macro-
phages. Although some GFP-positiv·c T cells could be long-lived T 
cells that were originally adoptively transferred. multilincage 
hcmatopoietic reconstitution in secondary recipients suggests the 
engraftment of GFP-positive hematopoietic stem cells in GALT of 
WT intestine grafts transplanted simultaneously with GFP-positivc 
BM (Figure 7). 
Discussion 
The current study demonstrated sustained macrochimerism for 
more than 150 days in noncytoablated but conventionally immuno-
suppressed rat recipients of simultaneous 8M and intestine trans-
plantation. Macrochimerism was only scen when both marrow and 
intestine were transplanted together and either graft alone failed to 
develop persistent macroehimerism. Further analyses of in vivo 
propagation and in vitro CFU formation of cells isolated from 
intestine grafts proved the presence of infused marrow hematopoi-
etic stem cells in simultaneously transplanted intestine allografts 
(syngcneic to marrow stem cells) for at least ISO days. The 
development of macrochimerism was not hindered with the 
depletion of leukocytes from the GALT of intestine allografts. 
Thus. the study suggests that the inkstinal graft parenchyma plays 
A ·~b 
G 
• 
• I 
m.1 \" r. pp 
Figure 6. Colony-forming unit in culture (CFU-C) assay of isolated cells from 
WT intestine grafts cotransplanted with GFP-positive BM. (A-B) Naive GFP-
positive BM formed more than 300 colonies per 1.5 x 105 cells, and all of them were 
GFP positive under fluorescent microscopy. (C-D) BM cells taken from the reCipient of 
WT intestine plus GFP-positive BM formed comparable numbers of colonies as 
normal ACI animals, but very few GFP-positive colonies were found despite stable 
macrochimerism. (E-F) Cells isolated from PPs and MLNs of WT intestine grafts 
transplanted with GFP-positive BM developed GFP-positive colonies with a fre-
quency of 2 to 6 per t.5 x 105 cells. CFU-Cs of cells isolated from naive WT intestinal 
PPs and MLNs were 1 to 3 per 1.5 x 105 cells. (G) Mean numbers of colonies per 
1.5 x 105 cells (n = 3). Panels A, C, and E are under an inverted microscope; B, D. 
and F are under an Olympus SZx 12 fluorescence dissecting microscope with 
magnification wheel set at 7:-:', insets at 30X. SI indicates small intestine. 
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Table 2. Propagation of GFP-positive cells after adoptive transfer of cells isolated from intestine grafts into lethally irradiated WT recipients 
No. of 
Source and number of cells transferred recipients Survival, d 
% GFP'positive cells 
in the blood, day 100 
Without additional 8M cells 
None 
Naive GFP BM, 2 x 106 
Naive WT 8M, 2 " 10' 
ACI host BM 100 d after transplantation of WT 
intestine and GFP BM, 2" 106 
With 2 x 106 WT 8M cells 
Naive GFP MLNs andlor PPs, lOx 106 
WT graft MLNs andlor PPs 100 d after transplantation 
of WT Intestine and GFP BM. 8;< 106 to 12.4 ;< 106 
Data represent mean::: SD. 
NA indicatos not applicable. 
5 
2 
2 
3 
4 
3 
roles in infused marrow stelll cell engraftment and subsequent 
dOll0r-tvpe hematopoiesis. 
MIIlT()W or hlood stem cells arc known to home' and lodge in the 
bone marrow for differentiation. Previous dogma has indicated that 
the space needs to be neated in the bone marrow using myelotoxic 
procedures for infused stem cells to engraft. Howevel', marrow 
stem cells could engraft and maintain long-term chimerism in 
immunocompetent syngencic recipients without any myelotoxic 
procedure,1.2"-'2 suggesting that there probably are open bone 
marrow niches available for infu:,cd stcm cells. Without immuno-
logic harriers. freCJueney of engraftment i, shown to correlate with 
the number of infused stem cells eompcting with the number of 
host steill cells. Myelotoxic therapy in syngeneic recipients has 
been thus suggested to play hendicial roles in eliminating the host 
stCIll cells and increasing the competitivc ratios of infused stem 
eel" lWeI' host cells to home and cngraft. J3 On the other hand, 
engraftmcnt of allogeneic marrow stem cells into host bone 
marrow of nonmycloablated recipients is extremely limited. Al-
though the primary role of conditioning remains controversial. 
higher rates of initial cngraftment failure of MHC-mismatchcd 
ltllogeneic stem cells. compared with MHC-identical or syngeneic 
stem cells. indicate that considerablc immunologic barrier exists 
for the engraftlllent of infused allogcneic marrow cells into the 
marrow microell\·ironlllent. In fact. numbers of studies showed 
incrcasL'd allogeneic marrow stem cell engraftment by inhibiting 
alloreactivity using C04· and COli' T-cell depiction, cytoxan, and 
costimulatory blockade without profound mycloablation.9- 11 ..1 4." 
1 1 
c: 
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Figure 7. Propagation of 8M·derived GFP·positive cells engrafted in the graft 
GALT. Lethally irradiated WT rats were adoptively transferred with cells isolated from 
GALT of WT Inlestine grafts simultaneously transplanted with GFP-positive 8M. Flow 
cytometric analYSIS of peripheral blood was performed 100 days after irradiation and 
transfer. After adoptive transfer of cells Isolated from MLNs and PPs of naive GFP 
rats, a GFP-positive population was not identified. On the other hand. multllineage 
GFP-positive cells including T. B. and monocytes/macrophages (about 6%) were 
detected after Infusion of cells from 'NT intestine grafts transplanted with GFP-
positive BM at day 120. Pictures are representative of 3 different animals of each 
group. 
8,9,11,11,12 
> 100 
> 100 
·100 
> 100 
> 100 
NA 
> 96 
o 
11:': 0.8 
0.8:': 0.9 
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Thus, allogeneic marrow stcm cell engraftment into the host 
marrow microenvironment is a complicated task intluenccd by the 
degree of MHC disparity, quality and quantity of stem cells, 
immunosuppression or pretransplantation conditioning regimens, 
and alloimmune reactivity. An additional potentially critical factor 
is MHC disparity between donor stern eelb and the host marrow 
microenvironment. To clarify whether an MHC restriction exists 
between stern cells and the marrow microenvironment. several in 
vivo and in vitro experiments examine the engraftlllcnt and 
differentiation of stem cells with MHC-matched or -mismatched 
stromal cells3!d7 Although in clinical practice of bone marrow 
transplantation the significance of a syngeneic marrow microenvi-
ronment for the infused stem cells is uncertain, these experimental 
studies demonstrate the increased numbers of infused hematopoi-
etic progenitor celI:, in an MHC-matched microenvironment and 
suggest the existence of an MHC restriction between marrow stem 
cells and supporting microenvironment. 
Hematopoietic stem cells have been long known to exist outside 
of bone marrow in thc adult lifc.'A.JXJ9 Recent studies reveal that 
mesenchymal stem cells also are present in a variety of tissues 
besides in the hone marrow.40AI Although exact roles of stcm cells 
outside bone marrow in normal and disease conditions arc not 
elucidated, these studies indicate that adult extra-bone marrow 
tissues are capable of providing microenvironment for stem cells. 
Infused marrow stem cells in this study engraft into both the 
allogeneic marrow environment and syngeneic extra-marrow envi-
ronment (intestine graft). Considering that marrow is the primary 
site of stem cell engraftment. although the number is low, a 
relatively higher frequency of infused marrow-derived GFP-
positive CFU-Cs in graft PPs and MLNs than host bone marrow 
(6.5 ± 4.1 and 0.9 ± 0.1 versus 1.1 ± 0.3 colonies per I X lO5 
cells. respectively) at day 120 suggests that intestinal graft microen-
vironment is suitable for marrow stem cell engraftmcnt. Although 
the study did not analyze earlier time points, early enhanced 
chimerism in the bone marrow plus intestine transplantation group 
compared with intcstine or bone marrow alone transplantation 
group might suggest the migration and temporary engraftment of 
donor hematopoietic stem cells in the host bone marrow during the 
early posttransplantation period. 
Transplantation-induced early graft injury might result in the 
local production of growth factors and cytokines/chemokines, and 
such milieus could facilitate the homing of infused stem cells. 
However. third-party intestine grafts in this study failed to support 
macrocbimerism development. indicating that the intestine graft 
syngeneic to infused bone marrow, but not thc soluble factor, is 
crucial for marrow stem cell engraftment into intestine grafts in 
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noncytoahlated recipients. Thus. the preferential migration of 
infused marrow stem cells toward syngeneic intestine grafts might 
suggest the advantage of an MHC -identical microenvironment. 
III summary. this study demonstrates that infused allogeneic 
marrow cells induce macrochimerism when an intestine graft is 
simultaneously transplanted. Although macrochimerism after simul-
taneous transplantation of 8M and intestine tended to decrease 
over the prolonged period of 12 months, persistence of macrochi-
Illerism for a significantly prolonged time after transplantation 
indicates active roles of intestine allografts in supporting the 
cngraftment of infused marrow stem cells that are syngeneic to 
intestine grafts. By w,ing molecular and innovative tools, recent 
extensive efforts significantly advanced the understanding of 
hematopoietic stem cell behavior. growth factors, adhesion mol-
ecules. and other molecules (eg. extracellular matrix proteins),I,,4, 
However, the biology of hematopoietic stem cell engraftment into 
8M niches remains largely unknown. Although further studies are 
certainly required, data in this study provide new information in 
understanding the behavior of marrow stem cells. 
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